W
e read with interest the article by Krishnan et al. (1) reporting the healing of acute wounds in type 2 diabetic patients versus control subjects. The authors also reported the expression of vascular endothelial growth factor (VEGF)-A, VEGF-R2, and hypoxiainducible factor (HIF)-1␣ in intact skin biopsies from these groups of subjects.
We agree about the pivotal role played by HIF-1␣ in wound healing (2,3), which is in perfect agreement with our observation regarding lower expression of HIF-1␣ in chronic diabetic wounds (4)-not referred, however, by the authors. The authors' observation about a lack of difference in HIF-1␣ expression in unwounded skin between diabetic and control subjects is not surprising. The main stimulus for HIF-1␣ is hypoxia, and, as far as the tissues are not challenged, they will exhibit a basal, low level of HIF-1␣. Our comment about HIF-1␣ levels can even be extended to the other immunohistological data presented by the authors that were collected solely on biopsies from intact skin. As an example, the basal levels of VEGF are increased in unwounded skin of db/db mice (5) but react with a significant delay in the wound healing process. It is therefore better to not extrapolate the steady-state levels of different factors found in intact skin biopsies to their potential role and regulation during the wound healing process in which the main pathogenic mechanism could rely just on the inappropriate reaction to concerted stimuli. 
